ARC
HSTO

Absolute Return Capital’s Histogen Inc. Common Stock HSTO Stock Holding History

Absolute Return Capital’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-407
Closed -$742K – 1019
2014
Q2 		$742K Buy
+407
New +$544K 0.01% 752

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Absolute Return Capital's HSTO Position: Q3 2014 in Review

Absolute Return Capital sold out of Histogen Inc. Common Stock (HSTO) in Q3 2014, closing a stake of 407 shares — an estimated $742K sold.

Absolute Return Capital first reported a position in HSTO in Q2 2014 and held it in 1 quarter. The position peaked at $742K in Q2 2014. 34 funds tracked by Wall St. Rank hold HSTO as of Q3 2014.

  • Absolute Return Capital reported no remaining Histogen Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Absolute Return Capital sold 407 Histogen Inc. Common Stock shares in Q3 2014, an estimated $742K.
  • Absolute Return Capital first reported a position in Histogen Inc. Common Stock in Q2 2014 and held it in 1 quarter.
  • Absolute Return Capital's Histogen Inc. Common Stock position peaked at $742K in Q2 2014.
  • 34 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2014.

Based on Absolute Return Capital's 13F filing for Q3 2014, filed 14 Nov 2014.